Pneumococcal pneumonia: clinical features, diagnosis and management in HIV-infected and HIV noninfected patients

2009 ◽  
Vol 15 (3) ◽  
pp. 236-242 ◽  
Author(s):  
Giordano Madeddu ◽  
Alessandro Giuseppe Fois ◽  
Pietro Pirina ◽  
Maria Stella Mura
2021 ◽  
Vol 8 (4) ◽  
Author(s):  
Saeed Shoar ◽  
Fernando H Centeno ◽  
Daniel M Musher

Abstract Background Long regarded as the second most common cause of community-acquired pneumonia (CAP), Haemophilus influenzae has recently been identified with almost equal frequency as pneumococcus in patients hospitalized for CAP. The literature lacks a detailed description of the presentation, clinical features, laboratory and radiologic findings, and outcomes in Haemophilus pneumonia. Methods During 2 prospective studies of patients hospitalized for CAP, we identified 33 patients with Haemophilus pneumonia. In order to provide context, we compared clinical findings in these patients with findings in 36 patients with pneumococcal pneumonia identified during the same period. We included and analyzed separately data from patients with viral coinfection. Patients with coinfection by other bacteria were excluded. Results Haemophilus pneumonia occurred in older adults who had underlying chronic lung disease, cardiac conditions, and alcohol use disorder, the same population at risk for pneumococcal pneumonia. However, in contrast to pneumococcal pneumonia, patients with Haemophilus pneumonia had less severe infection as shown by absence of septic shock on admission, less confusion, fewer cases of leukopenia or extreme leukocytosis, and no deaths at 30 days. Viral coinfection greatly increased the severity of Haemophilus, but not pneumococcal pneumonia. Conclusions We present the first thorough description of Haemophilus pneumonia, show that it is less severe than pneumococcal pneumonia, and document that viral coinfection greatly increases its severity. These distinctions are lost when the label CAP is liberally applied to all patients who come to the hospital from the community for pneumonia.


Vaccine ◽  
2014 ◽  
Vol 32 (13) ◽  
pp. 1460-1465 ◽  
Author(s):  
Chamira Rodrigo ◽  
Thomas Bewick ◽  
Carmen Sheppard ◽  
Sonia Greenwood ◽  
Caroline Trotter ◽  
...  

PEDIATRICS ◽  
2014 ◽  
Vol 134 (4) ◽  
pp. e1149-e1162 ◽  
Author(s):  
M. E. M. Pierpont ◽  
P. L. Magoulas ◽  
S. Adi ◽  
M. I. Kavamura ◽  
G. Neri ◽  
...  

Non-gonococcal urethritis (NGU) is caused by Chlamydia trachomatis in 11–50% of cases, but Mycoplasma genitalium is being increasingly recognized as a common cause. Mycoplasma genitalium is not as well understood, and experience with treatment is limited; however, antibiotic resistance is already a problem. Asymptomatic in up to 20% of men, symptoms include dysuria and urethral discharge. Mucopurulent cervicitis is the female equivalent, but is less well defined. This chapter describes the aetiology, clinical features, complications, and investigations and management of NGU, and mucopurulent cervicitis. Management of recurrent and persistent urethritis is also covered, including a separate section for diagnosis and management of Mycoplasma genitalium.


This chapter summarizes clinical features, causes, diagnosis, and management of different groups of presentations or situations that need to be managed in genitourinary medicine or sexual health settings. Algorithms are provided for the different topics covered. The topics are listed at the beginning of the chapter.


Sign in / Sign up

Export Citation Format

Share Document